Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05875129 · ClinicalTrials.gov registry record · NA
Device Feasibility and Acceptability to Improve Insomnia in Cancer
A NA study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05875129 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 15 participants.
The verdict
NCT05875129, a NA study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Sleep disruption is common among young adult cancer survivors for a variety of reasons. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to improve chronic sleep disorders. This project will test the feasibility and acceptability of a new voice-activated virtual assistant (VAVA) device to deliver CBT-I to improve sleep among young adult cancer survivors with chronic sleep disorders.
Interventions
- DEVICE VAVA prototype
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05875129
The ClinicalTrials.gov registry entry for NCT05875129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VAVA prototype is the first listed.
NCT05875129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05875129 about?
NCT05875129 is a clinical study titled "Device Feasibility and Acceptability to Improve Insomnia in Cancer". Sleep disruption is common among young adult cancer survivors for a variety of reasons. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to improve chronic sleep disorders. This project will test the feasibility and acceptability of a new voice-activated virtual assistant (VAVA) devi...
What is the current status of trial NCT05875129?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-07-20. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05875129?
The interventions under investigation include: VAVA prototype (DEVICE).
Who is sponsoring clinical trial NCT05875129?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.